Maternal immunization with pneumococcal 9-valent conjugate vaccine and early infant otitis media

Vaccine

Volumn 32, Issue 51, 2014, Pages 6948-6955

  Daly, Kathleen A ^a   Scott Giebink, G ^a   Lindgren, Bruce R ^b   Knox, JoAnn ^a   Haggerty, Betty Jo ^c   Nordin, James ^c   Goetz, Sarah ^a   Ferrieri, Patricia ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c HEALTHPARTNERS RESEARCH FOUNDATION   (United States)

Author keywords

Maternal immunization; Otitis media; Pneumococcal antibodies; Pneumococcus

Indexed keywords

MATERNAL ANTIBODY; PLACEBO; PNEUMOCOCCUS VACCINE; VACCINE;

ADULT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; INCIDENCE; INFANT; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; MATERNAL TREATMENT; OTITIS MEDIA; PREDICTOR VARIABLE; PREGNANT WOMAN; PRIORITY JOURNAL; SEROTYPE; SIBLING; TREATMENT DURATION; TYMPANOSTOMY TUBE; UNSPECIFIED SIDE EFFECT; UPPER RESPIRATORY TRACT INFECTION; IMMUNOLOGY; MALE; NEWBORN; PASSIVE IMMUNIZATION; PNEUMOCOCCAL INFECTIONS; PREGNANCY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; FEMALE; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNIZATION; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; OTITIS MEDIA; PLACEBOS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PREGNANCY; TREATMENT OUTCOME; VACCINES, CONJUGATE;

EID: 84924020703     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.10.060     Document Type: Article

References (30)

1. Amstey M.S. The potential for maternal immunization to protect against neonatal infections. Semin Perinatol 1991, 15:206-209.
2. Insel R.A., Amstey M., Woodin K., Pichichero M. Maternal immunization to prevent infectious diseases in the neonate or infant. Int J Technol Assess Health Care 1994, 10:143-153.
3. Mooi F.R., de Greeff S.C. The case for maternal vaccination against pertussis. Lancet Infect Dis 2007, 7:614-624.
4. Salazar J.C., Daly K.A., Giebink G.S., Lindgren B.R., Liebeler C.L., Meland M., et al. Low cord blood pneumococcal immunoglobulin G (IgG) antibodies predict early onset acute otitis media in infancy. Am J Epidemiol 1997, 145:1048-1056.
5. Teele D.W., Klein J.O., Rosner B., the Greater Boston Otitis Media Study Group. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis 1989, 160:83-94.
6. Homøe P., Christensen R.B., Bretlau P. Acute otitis media and age at onset among children in Greenland. Acta Otolaryngol 1999, 119:65-71.
7. Black S., Shinefield H., Fireman B., Lewis E., Ray P., Hansen J.R., et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 2000, 19:187-195.
8. Eskola J., Kilpi T., Palmu A., Jokinen J., Haapakoski J., Herva E., et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001, 344:403-409.
9. Kilpi T., Ahman H., Jokinen J., Lankinen K.S., Palmu A., Savolainen H., et al. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children. Clin Infect Dis 2003, 37:1155-1164.
10. Bluestone C.D., Stephenson J.S., Martin L.M. Ten-year review of otitis media pathogens. Pediatr Infect Dis J 1992, 11:S7-S11.
11. Block S.L., Hedrick J., Harrison C.J., Tyler R., Smith A., Findlay R., et al. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J 2004, 23:829-833.
12. Casey J.R., Pichichero M.E. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr Infect Dis J 2004, 23:824-828.
13. Giebink G.S. The prevention of pneumococcal disease in children. N Engl J Med 2001, 345:1177-1183.
14. Daly K.A., Toth J.A., Giebink G.S. Pneumococcal conjugate vaccines as maternal and infant immunogens: challenges of maternal recruitment. Vaccine 2003, 21:3473-3478.
15. Wernette C.M., Frasch C.E., Madore D., Carlone G., Goldblatt D., Plikaytis B., et al. Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides. Clin Diagn Lab Immunol 2003, 10:514-519.
16. Quataert S.A., Rittenhouse-Olson K., Kirch C.S., Hu B., Secor S., Strong N., et al. Assignment of weight-based antibody units for 13 serotypes to a human antipneumococcal standard reference serum, lot 89-S(F). Clin Diagn Lab Immunol 2004, 11:1064-1069.
17. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 1988, 75:800-802.
18. Wood K.J., Bushell A.R., Jones N.D. The discovery of immunological tolerence: now more than just a laboratory solution. J Immunol 2010, 184:3-4.
19. Malhotra I., Dent A., Mungai P., Wamachi A., Ouma J.H., Narum D.L., et al. Can prenatal malaria exposure produce an immune tolerant phenotype? A prospective birth cohort study in Kenya. PLoS Med 2009, 6:e1000116. 10.1371/journal.pmed.1000116.
20. van Santen K.L., Bednarczyk R.A., Adjaye-Gbewonyo D., Orenstein W.A., Davis R., Omer S.B. Effectiveness of pneumococcal conjugate vaccine in infants by maternal influenza vaccination status. Pediatr Infect Dis J 2013, 32:1180-1184.
21. Kaplan E.L., Top F.H., Dudding B.A., Wannamaker L.W. Diagnosis of streptococcal pharyngitis: differentiation of active infection from the carrier state in the symptomatic child. J Infect Dis 1971, 123:490-501.
22. Chonmaitree T., Revai K., Grady J.J., Clos A., Patel J.A., Nair S., et al. Viral upper respiratory tract infection and otitis media complication in young children. Clin Infect Dis 2008, 46:815-843.
23. Heikkinen T., Chonmaitree T. Importance of respiratory viruses in acute otitis media. Clin Microbiol Rev 2003, 16:230-241.
24. Heikkinen T. Role of viruses in the pathogenesis of acute otitis media. Pediatr Infect Dis J 2000, 19:S17-S23.
25. Doyle W.J., Winther B., Alper C.M. Daily tympanometry for high-resolution measurement of the time between onset of cold-like illness and middle ear effusion. Laryngoscope 2008, 118:1066-1071.
26. Vesa S., Kleemola M., Blomqvist S., Takala A., Kilpi T., Hovi T. Epidemiology of documented viral respiratory infections and acute otitis media in a cohort of children followed from two to twenty-four months of age. Pediatr Infect Dis J 2001, 20:574-581.
27. Henderson F.W., Collier A.M., Sanyal M.A., Watkins J.M., Fairclough D.L., Clyde W.A., et al. A longitudinal study of respiratory viruses and bacteria in the etiology of acute otitis media with effusion. N Engl J Med 1982, 306:1377-1383.
28. Paterson J.E., Carter S., Wallace J., Ahmad Z., Garrett N., Silva P.A. Pacific Island families study: risk factors associated with otitis media with effusion among Pacific 2-year-old children. Int J Pediatr Otorhi 2007, 71:1047-1054.
29. Vernacchio L., Lesko S.M., Vezina R.M., Corwin M.J., Hunt C.E., Hoffman H.J., et al. Racial/ethnic disparities in the diagnosis of otitis media in infancy. Int J Pediatr Otorhi 2004, 68:795-804.
30. Daly K.A., Brown J.E., Lindgren B.R., Meland M.H., Le C.T., Giebink G.S. Epidemiology of otitis media onset by six months of age. Pediatrics 1999, 103:1158-1166.